Rehmann Capital Advisory Group’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$253K Buy
6,583
+176
+3% +$6.76K 0.02% 518
2025
Q1
$248K Buy
6,407
+279
+5% +$10.8K 0.02% 530
2024
Q4
$207K Buy
6,128
+520
+9% +$17.6K 0.01% 571
2024
Q3
$232K Buy
5,608
+332
+6% +$13.8K 0.02% 540
2024
Q2
$203K Buy
5,276
+336
+7% +$12.9K 0.01% 554
2024
Q1
$212K Buy
+4,940
New +$212K 0.02% 537
2022
Q3
Sell
-3,985
Closed -$217K 535
2022
Q2
$217K Buy
+3,985
New +$217K 0.02% 451
2019
Q3
$186K Sell
3,479
-95
-3% -$5.07K 0.02% 324
2019
Q2
$179K Buy
3,574
+321
+10% +$16.1K 0.02% 459
2019
Q1
$170K Buy
3,253
+1,032
+46% +$53.9K 0.02% 450
2018
Q4
$106K Buy
2,221
+159
+8% +$7.59K 0.02% 393
2018
Q3
$104K Sell
2,062
-222
-10% -$11.1K 0.01% 577
2018
Q2
$115K Sell
2,284
-1,213
-35% -$61.1K 0.02% 524
2018
Q1
$171K Buy
+3,497
New +$171K 0.03% 410
2017
Q4
Sell
-5,207
Closed -$264K 395
2017
Q3
$264K Sell
5,207
-507
-9% -$25.7K 0.05% 297
2017
Q2
$308K Sell
5,714
-912
-14% -$49.2K 0.06% 241
2017
Q1
$349K Sell
6,626
-202
-3% -$10.6K 0.06% 246
2016
Q4
$329K Sell
6,828
-383
-5% -$18.5K 0.06% 249
2016
Q3
$389K Sell
7,211
-139
-2% -$7.5K 0.08% 211
2016
Q2
$398K Buy
7,350
+192
+3% +$10.4K 0.07% 210
2016
Q1
$363K Sell
7,158
-629
-8% -$31.9K 0.07% 213
2015
Q4
$393K Buy
7,787
+598
+8% +$30.2K 0.08% 186
2015
Q3
$346K Buy
7,189
+2,004
+39% +$96.5K 0.08% 196
2015
Q2
$270K Sell
5,185
-61
-1% -$3.18K 0.06% 250
2015
Q1
$303K Sell
5,246
-98
-2% -$5.66K 0.07% 234
2014
Q4
$285K Sell
5,344
-650
-11% -$34.7K 0.07% 246
2014
Q3
$344K Buy
5,994
+118
+2% +$6.77K 0.08% 201
2014
Q2
$393K Buy
5,876
+134
+2% +$8.96K 0.09% 182
2014
Q1
$384K Sell
5,742
-115
-2% -$7.69K 0.1% 165
2013
Q4
$391K Buy
5,857
+333
+6% +$22.2K 0.12% 163
2013
Q3
$346K Buy
5,524
+177
+3% +$11.1K 0.11% 169
2013
Q2
$334K Buy
+5,347
New +$334K 0.12% 162